Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine

NCT00482027 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

International AIDS Vaccine Initiative

Collaborators